Lumos Pharma, Inc.
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phas…
Biotechnology
US, Austin [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Lumos Pharma, Inc. has no acquisition track records yet.
M&A Deals · History
Lumos Pharma, Inc. has no acquisition track records yet.